Literature DB >> 3383139

"Chordoid" meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases.

J J Kepes1, W Y Chen, M H Connors, F S Vogel.   

Abstract

Seven young patients ranging in age from 8 to 19 years had surgically removed meningeal neoplasms with a peculiar myxoid-chordoid pattern. The tumors were surrounded by massive polyclonal lymphoplasmacellular infiltrates with follicles and germinal centers. The patients preoperatively manifested iron-resistant hypochromic microcytic anemia, and one of them had dysgammaglobulinemia and stunted growth. After the masses were removed, the blood picture of the patients normalized, and the adolescent with retarded somatic development resumed normal growth, but two patients developed local recurrence with identical histology and again became anemic. It appears that the peritumoral lymphoplasmacellular infiltrates, which in these instances may be regarded as reactive rather than primary cell proliferations, nevertheless brought about the type of systemic manifestations known as the Castleman syndrome, characteristically seen in patients with angiofollicular lymphoid hyperplasia (hamartoma) of soft tissues, or Castleman's tumor. In one of our patients the inflammatory infiltrate extended far into the surroundings of the meningioma, resulting in the erroneous initial diagnosis of "encephalitis" from a needle biopsy of the brain near the tumor.

Entities:  

Mesh:

Year:  1988        PMID: 3383139     DOI: 10.1002/1097-0142(19880715)62:2<391::aid-cncr2820620226>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

1.  Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution.

Authors:  Jui-Wei Lin; Jih-Tsun Ho; Yu-Jun Lin; You-Ting Wu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

Review 2.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

4.  Report of two cases of chordoid meningioma in patients with Castleman syndrome.

Authors:  Gentian Kaloshi; Manila Antonelli; Gjergj Vreto; Artid Lame; Ilda Kerri; Teona Bushati; Arben Rroji; Mentor Petrela
Journal:  J Neurooncol       Date:  2010-12-07       Impact factor: 4.130

Review 5.  Predictors of recurrence in the management of chordoid meningioma.

Authors:  Winward Choy; Leonel Ampie; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  J Neurooncol       Date:  2015-09-26       Impact factor: 4.130

6.  Chordoid meningioma presenting as painful orbital apex syndrome in pregnancy.

Authors:  Andrew Scott; Eamon Sharkawi; Caroline Micallef; Paul Johns; Laura Grant
Journal:  Int Ophthalmol       Date:  2007-09-26       Impact factor: 2.031

7.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

8.  Primary chordoid meningioma of lung.

Authors:  Corwyn Rowsell; Jane Sirbovan; Marc K Rosenblum; Bayardo Perez-Ordoñez
Journal:  Virchows Arch       Date:  2005-02-16       Impact factor: 4.064

9.  Meningeal Castleman's disease with multifocal involvement: a case report and review of literature.

Authors:  Santiago Coca; Isabel Salas; Roberto Martínez; Miguel Angel Saez; Jesús Vaquero
Journal:  J Neurooncol       Date:  2008-01-18       Impact factor: 4.130

10.  Optic neuropathy associated with Castleman disease.

Authors:  Ungsoo Kim; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2010-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.